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ABSTRACT
TGR5 is a member of the G protein-coupled receptor family and is activated by bile acids. TGR5 is thought to be a
promising food factor target for preventing metabolic diseases because the activation of TGR5 prevents obesity and
hyperglycemia in mice fed a high-fat diet. In the present study, we established an evaluation system for the TGR5 ligand activity,
and identified a limonoid nomilin as an activator of TGR5 from among approximate 150 purified food compounds. Unlike bile
acids, nomilin did not exhibit the farnesoid X receptor ligand activity. Although the nomilin derivative obacunone was capable of
activating TGR5, limonin (the most abundant limonoid in citrus seeds) was not a TGR5 activator. When male C57BL/6J mice fed
a high-fat diet for 9 weeks were further fed a high-fat diet either alone or supplemented with 0.2% w/w nomilin for 77 days,
nomilin-treated mice had lower body weight, serum glucose, serum insulin, and enhanced glucose tolerance. Our results suggest
a novel biological function of nomilin as an agent having anti-obesity and anti-hyperglycemic effects that are likely to be
mediated through the activation of TGR5.
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INTRODUCTION
The prevalence of metabolic disorders including
obesity and type 2 diabetes is increasing at an alarming
rate worldwide(1). Since these metabolic disorders can
cause cardiovascular disease and life-threatening
complications including blindness, kidney failure, and
heart disease, huge efforts are directed at finding new
drugs and functional foods that can cure these disorders
and/or prevent their development.
TGR5, a novel G protein-coupled receptor, is
activated by bile acids (BAs), and its activation results in
the elevation of intracellular cAMP levels(2,3). TGR5 is
expressed in brown adipose tissue (BAT) where its
activation by BAs increases energy expenditure and
attenuates diet-induced obesity in mice(4). This metabolic
effect of BAs is considered to be mediated by the
induction of the cAMP-dependent thyroid hormone
activating enzyme type 2 iodothyronine deiodinase
(DIO2) in BAT(4). Furthermore, TGR5 is expressed in
enteroendocrine L cells, and its activation induces
intestinal glucagon-like peptide-1 (GLP-1) release,
thereby leading to improved liver and pancreatic function
and enhancing glucose tolerance in obese mice(5). These
emerging data indicate that TGR5 is an attractive target
for the potential prevention and treatment of metabolic
disorders(6). To date, several compounds including BA
derivatives(7-10), oleanolic acid(11) present in Olea
europaea leaves, and betulinic acid(12,13) that is widely
distributed throughout the plant kingdom have been
identified as TGR5 ligands.

To evaluate the TGR5 ligand activity of food factors,
we aimed to generate a new assay system in which an
increase in the cAMP level in response to the activation
of TGR5 is detected using cultured cells with
exogenously-expressed human TGR5. We identified a
limonoid nomilin as an activator of TGR5 from among
approximate 150 purified food compounds that are
commercially available.
Limonoids are highly oxygenated triterpenoid
compounds contained in Citrus. Citrus seeds contain
approximately 1% (fresh weight percentage) limonoids.
Although the relative composition of limonoids in Citrus
seeds depends on the species, limonin and nomilin are the
major limonoids(14). Because limonin is responsible for
the delayed bitterness of citrus juices, its occurrence
lowers the quality and value of these juices(15). Limonoids
exhibit several pharmacological activities such as
anti-cancer,
anti-malarial,
and
anti-microbial
activities(16,17). However, the effect of limonoids on
metabolic disorders is largely unknown.

MATERIALS AND METHODS
I. Reagents
Nomilin (purity, 98.09%) was purchased from
Waterstone Technology. Obacunone (purity, 85.8%) was
purchased from ChromaDex. Chenodeoxycholic acid
(CDCA; purity, ≥ 98%) and limonin (purity, ≥ 90%) were
purchased from Sigma.
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II. Plasmid Constructs
A pCRE-Luc reporter plasmid containing 4 copies of
consensus sites for the cAMP response element (CRE)
was obtained from Agilent Technologies. An expression
plasmid for TGR5, pcDNA-TGR5, was constructed by
inserting a 1.0-kb PCR fragment encoding full-length
human TGR5 into a pcDNA3.1 vector (Invitrogen).
Another reporter plasmid, pG5Luc, which contained 5
copies of GAL4 binding sites, has been described
previously(18). Moreover, an expression plasmid for the
GAL4 DNA-binding domain(DBD)-farnesoid X receptor
(FXR) fusion protein, pGAL4-FXR, has been described
previously(19,20).
III. 0.2% Nomilin Feeding for 77 Day
Mice (n = 8) were fed a pelleted HFD for 8 weeks
and subsequently fed a powdered HFD for 1 week to
allow adaptation to a powdered diet. The mice were then
divided into 2 groups of similar average body weight and
blood glucose levels; one group of mice was fed a HFD
(HF; n = 4), and the second group was fed a nomilin
supplemented HFD (HF + Nomilin; n = 4). Food intake
was measured daily in the HF + Nomilin group, and the
same amount of food was provided to the HF group. The
mice were weighed every 4 d. At 66 d after the initiation
of nomilin supplementation, an oral glucose tolerance test
(OGTT) was performed. At the end of 77 d, the mice
were fasted for 4 h and killed under anesthesia. BAT and
epididymal white adipose tissue (WAT) were rapidly
excised, frozen in liquid nitrogen, and stored at -80°C
until further processing.
IV. OGTT
OGTT was performed at 66 d after the initiation of
nomilin supplementation. After a 16 h period of food
deprivation, glucose (2 g/kg body weight) in water was
administered orally by gavage. Plasma glucose levels
were measured from tail blood before and 15, 30, 45, 60,
90, 120, and 150 min after administration with a handheld
glucometer (Ascensia Breeze 2, Bayer Diagnostic).

RESULTS
I. Nomilin Is a TGR5 Agonist
We performed reporter assays using a TGR5
expression plasmid and a CRE-driven luciferase reporter
plasmid (Figure 1) and found nomilin to be a potent
TGR5 agonist. Consistent with previous results(7), 100
μM CDCA increased (p < 0.01) the CRE-driven
luciferase expression level only when TGR5 was
expressed in HEK293 cells. Moreover, nomilin
stimulated (p < 0.01) luciferase activity only in the
presence of TRG5 in a dose-dependent manner,
indicating that nomilin exhibits TGR5 ligand activity.
Because BAs are dual agonists of TGR5 and FXR, we
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next examined whether nomilin stimulated FXR.
Although CDCA activated (p < 0.01) the GAL4-DBD
fused FXR, nomilin had no effect.
TGR5
HEK293 cells

CRE-CRE-CRE---Luciferase
Figure 1. A reporter assay system to evaluate TGR5 ligand
activities.

II. Obacunone, But Not Limonin, Is a TGR5 Agonist
Next, we examined whether other limonoids derived
from nomilin, the most abundant limonoid limonin and
obacunone, exhibited TGR5 ligand activity. Although
100 μM obacunone increased (p < 0.01) the CRE-driven
luciferase expression level in the presence of TGR5 as
well as nomilin, 100 μM limonin did not stimulate
luciferase activity at all, indicating that obacunone, but
not limonin, is another TGR5 agonist.
III. Nomilin Supplementation with HFD Suppresses
Diet-induced Obesity and Serum Glucose and Insulin
Levels
The mice were pair-fed either a HFD (HF) or HFD
supplemented with 0.2% nomilin (HF + Nomilin) for 77 d.
Compared with the HF group, the HF + Nomilin group
had lower (p < 0.05) body weight at day 64 after nomilin
supplementation, and thiseffect continued until sacrifice.
Serum glucose (p < 0.05) and insulin (p < 0.01) levels as
well as epididymal WAT weight (p < 0.05) were lowered
by nomilin. An oral glucose tolerance test performed on
day 66 after nomilin supplementation revealed that the
HF + Nomilin group had enhanced (p < 0.05) glucose
tolerance. Nomilin did not affect serum TG, ALT, and
AST levels, whereas the serum NEFA level was lowered
(p < 0.01). Contrary to our expectations, the expression of
the key genes involved in energy expenditure, such as
DIO2, UCP1, CPT-1, ACO, and PGC-1β, was unchanged,
and PGC1α gene expression was reduced (p < 0.05) by
nomilin in BAT.

DISCUSSION
The results of the present study demonstrate that
nomilin activated TGR5 in in vitro luciferase reporter
assays. The mice fed a HFD supplemented with nomilin
had a lower body weight and blood glucose levels as well
as enhanced glucose tolerance compared with mice fed a
nomilin-free HFD. These results clearly indicate that
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dietary nomilin ameliorates some metabolic abnormalities
in HFD-fed mice.
BAT is a major organ for cold- and diet-induced
adaptive thermogenesis in rodents and primates. Adaptive
thermogenesis is an energy dissipation process that occurs
without accompanying ATP production(21). Because
obesity occurs when energy intake exceeds energy
expenditure, acceleration of adaptive thermogenesis is
considered to be an important target for combating
obesity. BAs activate TGR5 that in turn elevates
intracellular cAMP levels in BAT(4). This elevation leads
to an increase in the expression of key genes involved in
energy expenditure, including DIO2 that encodes an
enzyme catalyzing the conversion of thyroxine into
3,5,3′-triiodothyronine and PGC-1α(4). In a preliminary in
vivo experiment in which the dietary nomilin content was
gradually increased for 160 d, we observed that DIO2 and
PGC-1α gene expressions in BAT were enhanced by
nomilin concomitantly with weight loss in HFD-fed mice.
Taken together, these results suggest that dietary nomilin
can enhance energy expenditure in BAT through TGR5
activation. However, nomilin feeding for 77 d in Expt. 2
did not increase the expression of the key genes involved
in energy expenditure; instead, suppression of PGC-1α
gene expression was observed despite nomilin-dependent
weight loss in HFD-fed mice. Presently, the reason for
this discrepancy is unclear. Some differences in the
experimental conditions between the in vivo experiments
(feeding period 160 d vs. 77 d; nomilin content gradually
increased from 0.02 to 0.2% vs. 0.2%) may have been
responsible for this difference. In addition, the serum
NEFA level may have contributed to this difference.
Dietary nomilin (0.2% for 77 d) reduced the serum
NEFA level in HFD-fed mice, whereas this decrease was
not observed in mice fed a nomilin-containing HFD for
160 d. A number of studies have demonstrated that fatty
acids increase PGC-1α gene expression(22,23), and n-3
PUFAs including docosahexaenoic acid increase
intracellular cAMP levels(24), which could lead to the
elevated expression of the key genes involved in energy
expenditure. Therefore, the activation of TGR5 by dietary
nomilin may oppose the effects of decreased serum
NEFA levels, thereby resulting in no significant increase
in the expression of the key genes involved in energy
expenditure in BAT after consumption of nomilin for 77
d. However, the reason why the serum NEFA levels
differed in the two experiments remains unclear. Further
studies will be required to elucidate these differences.
In the present study, dietary nomilin lowered blood
glucose levels and brought about enhanced glucose
tolerance in HFD-fed mice. At present, the means by
which dietary nomilin impacts the blood glucose level
and glucose tolerance is unclear. It is conceivable that
dietary nomilin-mediated weight loss influences glucose
metabolism. TGR5 ligands stimulate secretion of GLP-1,
which is a known incretin hormone, from enteroendocrine
L cells and improves insulin sensitivity and glucose
tolerance in HFD-fed mice(5). Thus, dietary nomilin may
augment GLP-1 secretion through the activation of TGR5

ICoFF論文集.indd 382

Journal of Food and Drug Analysis, Vol. 20, Suppl. 1, 2012

in enteroendocrine L cells, thereby improving glucose
metabolism. It is interesting to note that dietary nomilin
has the potential to affect glucose metabolism in the gut
before absorption and increase energy expenditure in
BAT after absorption.
BAs are dual ligands for TGR5 and FXR(7), but
triterpenoids such as oleanolic acid and betulinic acid are
selective ligands for TGR5(11,12). In addition, in the
present study, we demonstrated that the highly
oxygenated triterpenoid nomilin is a selective ligand for
TGR5. Nomilin, obacunone, and limonin share a similar
structure; their B- to D-rings and side chains are identical.
Given that limonin did not activate TGR5, the presence of
an A′-ring is likely to inhibit its binding to TGR5.
An HFD containing 0.2% nomilin ingested for 77 d
did not alter serum ALT and AST levels, indicating that
nomilin is not toxic to mice although it does reduce food
intake. This reduction is believed to be due to the bitter
taste of nomilin. Limonoid glucosides are tasteless, and
limonin is detected at nanomolar levels in the plasma of
healthy humans 6 h after administration of limonin
glucoside (2.0 g in 200 mL of buffered water)(25).
Therefore, it is possible that the administration of nomilin
glucoside exerts the same effect as nomilin but without
the bitter taste.

CONCLUSIONS
Our study demonstrates that dietary nomilin
suppressed diet-induced obesity and hyperglycemia in
mice, and this function is mediated, at least in part, by the
activation of TGR5(26). Because we used purified nomilin,
it is essential to determine whether nomilin glucosides
and crude extracts of citrus fruits exhibit the same effect
as purified nomilin. This issue is now under investigation.
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